Polytherapeutic drug delivery implant targets cancer
This article was originally published in Clinica
Executive Summary
Kensey Nash has received a $100,000 cash boost from the US National Cancer Institute (NCI) to fund research on an implantable, bioresorbable polymer device for delivering chemotherapeutic drugs.